AKERO THERAPEUTICS INC CVR from 00973Y108
13F holders, Q2 2026 (June 30)1holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding AKERO THERAPEUTICS INC CVR from 00973Y108 in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holder was GAMMA Investing LLC ($0).
- Company
- AKERO THERAPEUTICS INC CVR from 00973Y108
- CUSIP
- 009CVR044
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 452 shares bought and 28 shares sold, net +424 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| GAMMA Investing LLC | 0.00% | New | 452 | $0 |
"% of holder's portfolio" is AKERO THERAPEUTICS INC CVR from 00973Y108's weight in each manager's 13F, not the share of AKERO THERAPEUTICS INC CVR from 00973Y108 the manager owns.